COVID-19 Research News

Surveillance testing, as well as other aspects of COVID-19 response, come to an end on Duke's campus.

Cancer patients said the COVID-19 pandemic heightened infection concerns, increased feelings of fear, and disrupted their care, according to a research questionnaire.

Production will enable human studies to determine whether the vaccine protects against a wide variety of coronaviruses, including those that cause COVID-19 

As chief operating officer at the Duke Human Vaccine Institute (DHVI), Thomas Denny is in the unique position of helping people fight flu and HIV, developing the next generation of COVID-19 vaccines, and all the while leading an annual $120 million enterprise.

A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no differences in relief of mild-to-moderate COVID-19 symptoms between participants taking ivermectin and participants taking a placebo.

A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no symptomatic or clinical benefit to taking the antidepressant fluvoxamine 50 mg twice daily for 10 days for the treatment of mild-to-moderate COVID-19 symptoms.

Dr. Wolfe emerged as a key figure at Duke during the pandemic, patiently explaining the threat to the public while helping shape both the hospital’s efforts to save patients’ lives and the university’s efforts to keep students safe.

Dr. Susanna Naggie and her colleagues at Duke University School of Medicine knew that COVID-19 was disproportionately impacting communities of color through higher rates of infection, severity of disease and associated adverse outcomes. Determined to be part of the solution, they set out to understand and address these disparities in real time.

Duke scientists have identified a previously unknown barrier that separates the bloodstream from smelling cells in the upper airway of mice, likely as a way to protect the brain. But this barrier also ends up keeping some of the larger molecules of the body’s immune system out, and that may be hindering the effectiveness of vaccines.

COVID exacted a huge toll on the wellbeing of health care workers. Already struggling with high levels of emotional exhaustion going into the pandemic, the problem grew even worse after two years of managing the crisis. Nurses have been especially hard hit.